FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics, namely to application of water-soluble polyelectrolyte complex kappa-carrageenan:chotosan with component ratio 1:10 i/v with molecular weight of kappa-carrageenan 311 kDa and with molecular weight of chitosan 115 kDa and degree of N-acetylation 6% as medication, possessing gastroprotective activity.
EFFECT: invention provides extension of arsenal of natural medications, possessing gastroprotective action, and prevention of ulcerogenic impact on stomach mucosa by creation of protective layer on its surface, as well as demonstrates larger efficiency of ulcer formation reduction in comparison with kappa-carrageenan and chitosan, taken separately.
2 cl, 4 ex, 4 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
HISTOCHROME DOSAGE FORM FOR ORAL ADMINISTRATION AND PROLONGED ACTION | 2017 |
|
RU2651042C1 |
MEANS WITH GASTROPROTECTIVE ACTIVITY | 2016 |
|
RU2629090C1 |
3-[3-(MORPHOLINE-4-YL)PROPYL]-2-[(2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-YL)METHYL-1,3-THIAZOLIDINE-4-ONE WITH ANTI-ULCER AND ANTI-INFLAMMATORY ACTIVITY | 2017 |
|
RU2643669C1 |
METHOD FOR PREPARING AGENT POSSESSING ANTIULCEROGENIC ACTION | 2013 |
|
RU2533228C2 |
METHOD FOR PREPARING ANTIULCER GASTRORETENTIVE AGENT | 2013 |
|
RU2531092C1 |
METHOD FOR PREVENTION OF ULCERATION OF GASTRIC MUCOSA | 2020 |
|
RU2744455C1 |
METHOD FOR PREPARING DRUG POSSESSING ANTIULCEROGENIC, ANTISTRESS AND HEMOSTATIC ACTIVITIES | 2012 |
|
RU2495674C1 |
13-E-(2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) EUDESMANOLIDES HAVING ANTIULCER ACTIVITY | 2013 |
|
RU2536870C1 |
AMIDE β GLYCIRRHIZIC ACID WITH PHENYLBORON ACID SHOWING ANTIINFLAMMATORY AND ANTIULCEROUS ACTIVITY | 1991 |
|
RU2032694C1 |
BIOLOGICALLY ACTIVE FOOD SUPPLEMENT "BIOSINOL", WHICH POSSESSES GASTROPROTECTIVE ACTIVITY | 2009 |
|
RU2397775C1 |
Authors
Dates
2014-12-20—Published
2014-01-28—Filed